Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
3.940
+0.040 (1.03%)
At close: Apr 10, 2026, 4:00 PM EDT
3.970
+0.030 (0.76%)
After-hours: Apr 10, 2026, 5:51 PM EDT
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $85.96 million as of April 10, 2026. Its market cap has decreased by -57.33% in one year.
Market Cap
85.96M
Enterprise Value
-23.63M
1-Year Change
-57.33%
Ranking
Category
Stock Price
$3.94
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $85.96M, a decrease of -74.88%. That is a compound annual growth rate of -69.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 85.96M | -69.92% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeonaBio | 91.02M |
| Anixa Biosciences | 90.19M |
| Vivani Medical | 88.03M |
| Verrica Pharmaceuticals | 87.78M |
| Spruce Biosciences | 87.30M |
| Inovio Pharmaceuticals | 86.85M |
| PolyPid | 82.25M |
| aTyr Pharma | 81.62M |